LANSOPRAZOLE | A090763 | MYLAN PHARMACEUTICALS INC
Highest NADAC/Unit
$0.1445
per ea
Lowest NADAC/Unit
$0.1045
per ea
Brand NDCs
0
Generic NDCs
5
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00378801593LANSOPRAZOLE DR 15 MG CAPSULE | $0.1445 | EA | Generic | — | 2026-10-21 |
| 00378803005LANSOPRAZOLE DR 30 MG CAPSULE | $0.1045 | EA | Generic | — | 2026-10-21 |
| 00378803077LANSOPRAZOLE DR 30 MG CAPSULE | $0.1045 | EA | Generic | — | 2026-10-21 |
| 00378803093LANSOPRAZOLE DR 30 MG CAPSULE | $0.1045 | EA | Generic | — | 2026-10-21 |
| 51079012108LANSOPRAZOLE DR 30 MG CAPSULE | $0.1045 | EA | Generic | — | 2026-10-21 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.